“…Whilst there were differences in methodology and staining thresholds for classification, the majority of patient samples were found to be GLUT-1 positive (1380/1709, 80.7%). There were 11 studies (579 patients) where all samples (100%) demonstrated positive staining for GLUT-1 [27,43,51,52,56,59,61,63,71,72,76,80] and a further 11 studies reported GLUT-1 expression in 70%-98% of tumour samples [23,53,55,60,64,[73][74][75][77][78][79]. GLUT-1 was significantly upregulated in tumours compared to adjacent healthy tissue.…”